Pharmaceuticals - Community Register


List of referrals for human medicinal products


Product name: Dexrazoxane
Also marketed in the EU under the name(s): Cardioxane, Cyrdanax, DEXRAZOXANE CYATHUS, Enaxozar, Procard
INN: Dexrazoxane
Indication: Prevention of chronic cumulative cardiotoxicity caused by doxorubicin or epirubicin use in advanced and/or metastatic adult breast cancer patients
Marketing Authorisation Holder: Not applicable


European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
15/09/2011 Referral EMEA/H/A-31/1275 (2011)6519 of 13/09/2011